Objective: Less invasive approaches to mitral valve surgery are increasingly used for improved cosmesis; however, few studies have investigated their effect on outcome. We sought to compare these minimally invasive approaches fairly with conventional full sternotomy by using propensity-matching methods.
Lars G. Svensson Objective: Less invasive approaches to mitral valve surgery are increasingly used for improved cosmesis; however, few studies have investigated their effect on outcome. We sought to compare these minimally invasive approaches fairly with conventional full sternotomy by using propensity-matching methods.
Methods: From January 1995 to January 2004, 2124 patients underwent isolated mitral valve surgery through a minimally invasive approach, and 1047 underwent isolated mitral valve surgery through a conventional sternotomy. Because there were important differences in patient characteristics, a propensity score based on 42 factors was used to obtain 590 well-matched patient pairs (56% of cases).
Results: In-hospital mortality was similar for propensity-matched patients: 0.17% (1/590) for those undergoing minimally invasive surgery and 0.85% (5/590) for those undergoing conventional surgery (P ¼ .2). Occurrences of stroke (P ¼ .8), renal failure (P>.9), myocardial infarction (P ¼ .7), and infection (P ¼ .8) were also similar. However, 24-hour mediastinal drainage was less after minimally invasive surgery (median, 250 vs 350 mL; P < .0001), and fewer patients received transfusions (30% vs 37%, P ¼ .01). More patients undergoing minimally invasive surgery were extubated in the operating room (18% vs 5.7%, P<.0001), and postoperative forced expiratory volume in 1 second was higher. Early after operation, pain scores were lower (P < .0001) after minimally invasive surgery.
Conclusion:
Within that portion of the spectrum of mitral valve surgery in which propensity matching was possible, minimally invasive mitral valve surgery had cosmetic, blood product use, respiratory, and pain advantages over conventional surgery, and no apparent detriments. Mortality and morbidity for robotic and percutaneous procedures should be compared with these minimally invasive outcomes. (J Thorac Cardiovasc Surg 2010;139:926-32) Supplemental material is available online.
In the mid-1990s, minimally invasive ''keyhole'' approaches for mitral valve operations were pioneered with the intent of reducing morbidity, postoperative pain, and blood loss; improving cosmesis; shortening hospital stay; and reducing cost compared with the 50-year-old conventional median sternotomy approach. [1] [2] [3] [4] [5] [6] [7] [8] Furthermore, it was believed that less spreading of the incision, no interference with the diaphragm, and less tissue dissection might improve outcomes, particularly respiratory function. 7, 8 Although clinical studies suggest that some of these benefits have been realized, there has been no confirmatory large study or randomized trial. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] Therefore, we performed a propensity-matched comparison of short-and long-term outcomes in patients who underwent minimally invasive mitral valve surgery with those who underwent conventional full sternotomy.
MATERIALS AND METHODS Patients
From January 1995 to January 2004, 3171 patients underwent isolated mitral valve surgery with or without tricuspid valve repair; patients undergoing concomitant aortic valve surgery, coronary artery bypass grafting, or reoperation were excluded, as were those with endocarditis. The more recently investigated approaches of right minithoracotomy and robotic procedures were not included because they were included in the armamentarium to treat mitral valve disease after this period. A minimally invasive approach was intended in 2124 (67%) patients, and conventional full median sternotomy was intended in 1047 patients. Unmatched patients' mean age was 57 AE 13 years (range, 18-89 years), and 58% were men.
Data were in part retrieved from the prospective Cardiovascular Information Registry and in part from each patient's medical record. These data were approved for use in research by the institutional review board, with patient consent waived.
Surgical Technique
Conventional general anesthesia was used in all patients, regardless of surgical approach. In those receiving a full median sternotomy, the mitral valve was usually visualized through an incision in the left atrium anterior to the right pulmonary veins. Patients who underwent minimally invasive surgery had a 3-to 4-inch (8-to 10-cm) skin incision. 1, 3, 7 Three minimally invasive approaches were included in this study. From 1995 through 1996, a right paramedian incision was used that included division of the third and fourth costal cartilages (158 [8.4%] patients) 1 ; from 1997 onward, this changed to a J incision beginning at the sternal notch and ending at the fourth intercostal space (1635 [87%] patients). 7, 8 From 1998 to 2004, 37 (1.8%) patients had a partial right lower sternotomy; choice of approach was at the surgeon's discretion. In this study, more recently introduced approaches, such as robotic or lateral minithoracotomy, were added after completion of the study.
With these minimally invasive chest-wall incisions, the mitral valve was accessed through a transseptal incision. Routine mitral valve repair and replacement techniques were used, and all types of complete repairs were possible through the minimally invasive incision. 1, 8, 10, 11 Vacuum-assisted cardiopulmonary bypass with central cannulation was used in all patients. 12 Intraoperative transfusions, anesthetic technique, and timing of extubation were at the anesthesiologist's discretion. Intraoperative and postoperative transfusion, extubation, and pain scores were not derived from protocols. Clearly, in the early phase of this study, there was a learning curve involved in developing the technique, which was, however, technically similar to conventional sternotomy.
Study Design
A number of differences in patient characteristics precluded direct comparison of outcomes (Table 1) . Therefore, to reduce the influence of selection, we used propensity matching to approximate a randomized trial. [13] [14] [15] In the spirit of such a trial, we followed the intent-to-treat principle, such that the 40 (1.9%) cases with an intended minimally invasive approach who were converted to conventional sternotomy were retained in the minimally invasive group. Initially, a parsimonious model based on variables in Appendix 1 was formulated by means of logistic regression analysis with bagging for variable selection (see Table E1 ) to understand the drivers of patient selection. 16 To this model were added nonsignificant variables to form a propensity model. From this, a propensity score was generated for each patient from a logistic regression model (C ¼ 0.86) based on 42 preoperative variables and procedure variables that were predictable preoperatively (Appendix 1). Greedy matching based on the propensity score was used to identify 590 patient pairs for comparison (see Table E2 ).
17 Figure 1 indicates the portion of the spectrum of propensity from which matched pairs were obtained, and Table E2 documents characteristics of patients for whom either minimally invasive or conventional approaches were more heterogeneously applied during the study period. Clearly, as seen from the figure, there is good overlap between the procedures after propen- 
Outcomes
Outcomes assessed included intraoperative support (myocardial ischemic and cardiopulmonary bypass times), postoperative in-hospital mortality and morbidity (defined in accordance with the Society of Thoracic Surgeons National Database http://www.ctsnet.org/file/rptDataSpecifications252_1_ ForVendorsPGS.pdf), blood product use, mediastinal drainage at 6 and 24 hours, hematocrit value at hospital discharge, time to extubation (which was at the discretion of attending anesthesiologists in either the operating room or intensive care unit), all incentive spirometric values after extubation, all pain scores, length of hospital stay, long-term survival, and recurrence of mitral regurgitation (MR) in patients undergoing repair.
Spirometry and pain scoring were performed and results were recorded prospectively from January 2000 to January 2004, during which time 536 matched patients underwent operations. Both spirometric values and pain scores were obtained routinely as part of clinical care from all patients after surgical intervention. Spirometry, consisting of forced expiratory volume in 1 second ([FEV 1 ] in milliliters), was performed periodically by respiratory therapists using a Renaissance II bedside spirometer (Puritan Bennett, Carlsbad, Calif) until hospital discharge; a total of 2234 values were available for 417 (78%) matched patients. FEV 1 values were normalized to the percentage of predicted value by using the National Health and Nutrition Examination Survey algorithm. 18 Pain intensity, ranging from 0 (none) to 10 (severe), was recorded by nursing staff from the patient's arrival in the intensive care unit to hospital discharge by using the extensively validated Wong-Baker visual-analog scale. 19, 20 A total of 18,061 pain scores were available for 454 (85%) matched patients.
Survival was assessed by follow-up every 2 years by using an institutional review board-approved questionnaire supplemented by the Social Security Death Index. 21, 22 A total of 5296 patient-years of information was available for analyses among matched patients, with a mean follow-up of 4.5 AE 2.5 years; 25% of survivors were followed for more than 6.8 years, and 10% were followed for more than 8 years. For matched patients undergoing minimally invasive surgery, 2787 patient-years of follow-up were available for analyses, mean follow-up was 4.7 AE 2.3 years, and 10% were followed more than 7.9 years. For matched patients undergoing conventional sternotomy, 2509 patient-years of follow-up were available for analyses. Mean follow-up was 4.2 AE 2.7 years, and 10% were followed more than 8.4 years.
Recurrence of MR in patients undergoing repair was assessed by using the transthoracic echocardiographic grade of postoperative MR. A total of 2039 postoperative echocardiograms were available for 816 matched patients undergoing repair (90% of total matched patients undergoing repair), with a median follow-up of 1.3 months (minimum, 1 day; maximum, 14 years; Figure 2 ).
Comparisons
Categorical outcomes were compared by using either the c 2 or Fisher's exact test, and continuous outcomes were compared by using the t test or Wilcoxon rank-sum nonparametric test for skewed distributions. To compare the temporal pattern of postoperative FEV 1 across time, the repeated continuous values were analyzed longitudinally by using mixed-model regression, 17 with autoregressive order 1 correlation structure to accommodate the correlated nature of the observations within each patient.
To compare the temporal pattern of postoperative pain across time, pain scores were combined into 5 categories because of low frequency of higher pain scores: 0 (pain score 0), 1 (pain scores 1-3), 2 (pain scores 4-6), 3 (pain scores 7 and 8), and 4 (pain scores 9 and 10). Pain score category was analyzed longitudinally by using a nonlinear cumulative logit mixed model for repeated measures that resolved a number of temporal components and their shaping parameters. 23 Each component was independently modulated by a time function with common random intercept. Survival was compared nonparametrically by using the Kaplan-Meier method and parametrically by using a temporal decomposition model. 23 To compare temporal pattern of postoperative MR across time, we have used a nonlinear cumulative logit mixed model, as described above. Because of low frequency, MR grades 3þand 4þwere collapsed together and treated as one category.
Presentation
Categorical variables are summarized as frequencies and percentages and continuous variables as means AE standard deviations or as equivalent 15th, 50th (median), and 85th percentiles (for consistency with AE1 standard deviation) when data were skewed. Asymmetric 68% confidence limits (CLs) are consistent with AE1 standard error. All analyses were performed with SAS statistical software version 9.1 (SAS Institute, Inc, Cary, NC).
RESULTS

Intraoperative Support
Among propensity-matched patients, ischemic time was slightly longer after a minimally invasive approach (65 AE 24 vs 62 AE 23 minutes, P ¼ .01), and cardiopulmonary bypass time was equivalent (85 AE 46 vs 84 AE 31 minutes, P ¼ .9).
In-hospital Mortality and Morbidity
In-hospital mortality was 0.17% (CL, 0.03%-0.56%) in the minimally invasive group and 0.85% (CL, 0.48%-1.4%) in the matched conventional group (P ¼ .2, Table 2 ). In-hospital complications occurred with similar frequency in matched groups (Table 2) .
Bleeding and Transfusion
Return to the operating room for bleeding was similar in matched groups (Table 2) ; however, mediastinal drainage was lower at 6 and 24 hours after a minimally invasive approach (100 mL [CL, 50-200 mL] and 250 mL [CL, 150-350 mL]) than after conventional sternotomy (150 mL [CL, 100-300 mL] and 350 mL [CL, 250-600 mL]) at these times (P < .0001). Transfusion was less frequent after minimally invasive surgery than after conventional surgery (Table 2) . However, hematocrit values at discharge were slightly lower after minimally invasive surgery (30% AE 3.5% vs 31% AE 3.7%, P < .0001).
Respiratory Function
A higher proportion of matched patients were extubated in the operating room after minimally invasive than conventional surgery (18% vs 5.7%, P <.0001). Median hours to extubation were also shorter (4.8 hours [CL, 2.2-10 hours] vs 5.6 hours [CL, 3.0-14 hours], P ¼ .001). FEV 1 was similar immediately after extubation; however, it remained constant in the minimally invasive group, but decreased in the conventional sternotomy group during the first 12 hours and increased thereafter ( Figure 3 ).
Postoperative Pain
The general temporal pattern of pain score categories is illustrated in Figure 4 , A. Over the first 24 postoperative hours, only about a third of patients were pain free, and this proportion increased to about 60% by day 3 and stabilized. Matched patients undergoing minimally invasive surgery had less pain in the first 24 hours after the operation (P < .0001) but similar pain scores thereafter (Figure 4, B) .
Length of Stay
Among matched patients, median postoperative length of stay was 6 days (CL, 4-10 days) after minimally invasive surgery and, similarly, 6 days (CL, 5-10 days) after conventional sternotomy (P ¼ .3).
Survival
Survival at 1, 5, and 8 years was 98%, 91%, and 86% after minimally invasive surgery and 96%, 89%, and 84% after conventional surgery among matched patients (P ¼ .07, Figure 5 ).
Return of Mitral Valve Regurgitation After Repair
Proportions of patients in MR grade 3þ or 4þ at 1 and 5 years were 4% and 5% after minimally invasive surgery and 6% and 7% after conventional surgery among matched patients (P > .1, Figure 6 ).
DISCUSSION
Patients are increasingly requesting less invasive mitral valve procedures. In an attempt to achieve this and also maintain or improve on results of full median sternotomy, we pioneered the approach of paramedian or J incision partial sternotomies. 1, 7 Other minimally invasive and endoscopic approaches were also pioneered. [2] [3] [4] [5] [6] When minimally invasive cardiac surgery was introduced in the 1990s, concern centered around longer operations, greater risk, and more complications for the perceived benefit of better cosmetic results, better respiratory function, and less pain and bleeding. Some approaches became less frequently used because of problems, such as with the paramedian incision, peripheral cannulation for cardiopulmonary bypass, and robotic surgery. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] 24 Others, such as endoscopic or partial sternotomy, particularly the J incision, have become more widely adopted.
1-10
Principal Findings
This study confirms the previously unproved perception that there are no disadvantages to minimally invasive surgery; that is, procedure time is not lengthened, risks are comparable or less, transfusions are less frequent, respiratory function is better, early postoperative pain is less, length of stay is comparable or shorter, long-term survival is comparable, and return of MR is uncommon and similar. Although there was no major difference in survival, it should be noted that hospital and 30-day survival was greater than 99% in both groups, and thus to show a difference in early postoperative risk would require a huge number of patients. Hence early and late operative results were not compromised.
Less perioperative bleeding and fewer blood transfusions are likely due to the less extensive mediastinal dissection required for the minimally invasive approach. Less pain is likely related to less surgical dissection, less spreading of the sternum, and no escalation of tension on the posterior rib head and costovertebral ligaments because the chest wall is not opened like a trap door. The better pulmonary function can be explained by no interference with the diaphragm or dissection along it. Also, with less chest wall pain, patients might have less splinting of the chest and thus can breathe more deeply.
Considerable interest has been directed recently toward percutaneous valves, including mitral valve coronary sinusbased devices or innovative leaflet approximation technologies. [25] [26] [27] [28] [29] [30] Mortality and morbidity results reported in this study should serve as a benchmark against which forthcoming percutaneous valve results are compared in otherwise good surgical candidates. Mortality of less than 1% and even 0.2% to 0.5% for minimally invasive surgery is to be expected, as well as stroke occurrence of less than 1.7%. Furthermore, as we reported previously, all patients should have 1þor less MR after mitral valve repair. [31] [32] [33] Whether percutaneous devices will convey a cost benefit, less pain, and shorter hospital stay over minimally invasive approaches remains to be seen, particularly with the likely higher costs of these devices. Since the closing date of this study (January 2006), we have increasingly used right minithoracotomy and robotic approaches. Indeed, currently, one quarter of our patients receive a conventional open approach, one quarter receive a mini-J incision, one quarter receive a minithoracotomy, and one quarter receive robotic surgery. We are currently conducting a prospective study to compare these approaches.
Limitations
Although heterogeneity in the use of minimally invasive mitral valve surgery provided the opportunity for comparisons with conventional surgery, clearly, as a group, patients undergoing conventional mitral valve surgery were sicker, with a less favorable prognosis ( Figures E1-E3 ), than those undergoing minimally invasive surgery. When a propensity score was used to match patients, the comparison groups were intermediate in risk, and differences in most outcomes appeared to be explained by differences in patient characteristics rather than surgical approach. Indeed, like randomized trials that address only that portion of the spectrum of disease for which equipoise is present, propensity methods address only that portion of the spectrum for which heterogeneity in practice is discovered. However, as shown in Figure 1 , matched patients cover the entire spectrum of propensity scores, although at both extremes of the spectrum, surgeons at Cleveland Clinic during the period of this study tended to use predominantly a minimally invasive or a conventional approach. Factors driving this decision are identified in Table 1 : obesity, cerebral vascular disease, left ventricular function, acuity, cause of disease, tricuspid valve regurgitation, era of operation, and intent to repair rather than replace the valve. We acknowledge that selection bias cannot be completely reversed by using propensity-based methods and, in this study, cannot completely overcome distinct surgeon preferences. Because treatment was not masked, patients' self-reporting of pain scores might have been biased as well. This is also a single-institution study, which limits its generalizability. Nevertheless, timing to extubation, spirometric values, and pain scores would largely have been uninfluenced by potential surgeon biases because these were determined or routinely collected by respiratory therapists, anesthesiologists, or nurses.
CONCLUSION
Minimally invasive mitral valve surgery has cosmetic, blood product use, respiratory, and pain advantages and no apparent detriments. We routinely use the approach for most complex mitral valve procedures, excluding those requiring additional procedures, such as coronary artery or aortic surgery. For patients with localized P2-related regurgitation, we tend to perform valve repair using a robotic approach. We are, however, prospectively evaluating the options of a right minimally invasive thoracotomy and robotic approaches. 
